Form D · Biotechnology

Oleander Medical Technologies LLC

Baton Rouge, LA · CIK 0001591185

Offering snapshot reported Jul 1, 2024 · SEC filing

Reported sold
$500K
Offering amount: $5M
Investors reported
4
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Jun 7, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 1, 2024Initial$500,000No comparison4SEC filing
Sep 29, 2020Amendment$2,225,000$221,400vs Oct 16, 201919SEC filing
Oct 16, 2019Amendment$2,003,600$1,353,600vs Oct 17, 201819SEC filing
Oct 17, 2018Amendment$650,000$350,000vs Nov 7, 20177SEC filing
Nov 7, 2017Amendment$300,000$150,000vs Feb 13, 20174SEC filing
Feb 13, 2017Initial$150,000No comparison1SEC filing
Nov 12, 2013Amendment$100,000$0vs Nov 12, 20131SEC filing
Nov 12, 2013Amendment$100,000$0vs Nov 6, 20131SEC filing
Nov 6, 2013Initial$100,000No comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-517523

Source: Form D, filed Jul 1, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Harry J Gould Iii Executive
Paige R. Miller Executive
Henry J. Mills Executive
Dennis Paul Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Louisiana Emerging Technology Center 340 E Parker Blvd.
Baton Rouge, LA, 70808